PhaseBio Pharmaceuticals Q2 EPS $(0.06) Up From $(0.98) YoY

PhaseBio Pharmaceuticals (NASDAQ:PHAS) reported quarterly losses of $(0.06) per share. This is a 93.88 percent increase over losses of $(0.98) per share from the same period last year.PhaseBio Pharmaceuticals (NASDAQ:PHAS) reported quarterly losses of $(0.06) per share. This is a 93.88 percent increase over losses of $(0.98) per share from the same period last year.